PET-based biomarkers in cancer

Positron-emission tomography (PET) is an imaging technique allowing tumor metabolism to be visualized. PET images provide a spatial distribution of the active tumor cells. We use these images to compute quantitative measures and correlate them with clinical data, specifically in breast cancer, brain tumors and other tumor types. The goal is to define PET-based biomarkers of tumor aggressiveness and response to therapies of utility in breast cancer management.


There are no publications on this topic yet, but they are coming


Our research on PET-based biomarkers in cancer is developed in tight collaboration with nuclear medicine physicians from the public health service of Castilla–La Mancha (SESCAM). Ana M. García Vicente, head of the Nuclear Medicine Unit of the Toledo University Hospital is our group’s reference for topics related to PET imaging. Moreover, other members from her team like Germán Jiménez Londoño have worked with us providing clinical insight and collaborating on the imaging data collection and processing.